Immunology Studies

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.

Researchers are studying the effects of Ginkgo biloba extract (EGb 761) on mild cognitive impairment (MCI) by examining blood markers before and after a 12-month treatment period in 100 patients. They are also assessing cognitive test scores. The study is expected to be complete by 2023.

Morató X et al (2023).
Sci Rep.
PubMed:
37012306

Cocultivation with Solanum nigrum and inoculation with Rhizophagus intraradices can improve plant photosynthesis and antioxidant defense to alleviate cadmium toxicity to soybean.

Wang X et al (2023).
Ecotoxicol Environ Saf.
PubMed:
37011513